多巴胺神经元中的Rit2沉默驱动了一个渐进的帕金森症表型
Patrick J Kearney1,2, Yuanxi Zhang3, Yanglan Tan4
1Brudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.
Research square
|June 9, 2023
概括
多巴胺神经元中Rit2的损失导致帕金森病类的运动缺陷和神经元死亡. 这种帕金森病模型显示了性别特异性差异,并且可以用DAT抑制或L-DOPA治疗.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 帕金森病 (PD) 涉及黑色物质紧体 (SNc) 中多巴胺神经元的损失.
- Rit2是一种已知的PD风险等位基因,其表达与PD患者队列相关.
- 在PD病变发生过程中Rit2损失的直接因果作用尚不清楚.
研究的目的:
- 调查Rit2损失是否导致帕金森病 (PD) 或PD类症状.
- 为了阐明在多巴胺 (DA) 神经元中Rit2缺乏的功能后果.
- 为了确定对Rit2损失的反应中潜在的性别特异性差异.
主要方法:
- 在小鼠的DA神经元中,有条件的Rit2沉默.
- 运动功能的评估,DA释放,条形DA含量和DA活性标记.
- 对SNc DA神经元存活率和α-synuclein酸化的分析.
- 通过DA载体 (DAT) 抑制和L-DOPA治疗对救援效应的评估.
主要成果:
- 条件Rit2沉默诱导了小鼠的进展性运动功能障碍,在雄性中比雌性更快地发生.
- 运动缺陷与减少DA释放,减少状DA含量和失去DAergic标记物有关.
- 观察到显著的SNc DA神经元损失和增加的pSer129-alpha同核素表达.
- 早期运动功能障碍通过DAT抑制或L-DOPA治疗得到改善.
结论:
- Rit2损失与SNc细胞死亡和PD类型的表型有因果关系.
- 这项研究确立了Rit2作为PD病变发生的关键因素.
- 在对Rit2损失的反应中发现了明显的性别特异性差异.
相关概念视频
01:24Parkinson's Disease: Treatment
305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305
01:15Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612
01:37Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K